Work

Prediction of acute kidney injury at the end of cardiac surgery using routine perioperative variables: a pre-specified benchmark of 210 machine learning combinations

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background Acute kidney injury after cardiac surgery (CSA-AKI) is common yet detected late. Risk stratification at the end of surgery could enable timely renal protection, but most machine learning (ML) models either use postoperative data or lack a transparent, pre-specified evaluation. Methods In a retrospective single-center cohort of 1,352 adult cardiac surgery patients (211 AKI, 15.6%), we predicted AKI from 32 routine preoperative and intraoperative (up to end-of-surgery) variables. We benchmarked 210 combinations (five feature-selection strategies × seven algorithms × six class weights) by repeated stratified 5-fold cross-validation (10 repeats) on a fixed development set ( n = 1,081), selected the final model by a pre-specified two-stage rule, and evaluated it once on a fixed test set ( n = 271). A screening-oriented threshold (sensitivity ≥0.80) was pre-specified. We additionally tested the few-shot transformer TabPFN, stability selection, bootstrap optimism correction, and simple ensembling, with SHAP for interpretability. Results The selected random forest (positive-class weighting, isotonic calibration) achieved a test-set AUC of 0.722 (95% CI 0.634–0.799), sensitivity 0.762, and specificity 0.515. No model family was decisively superior; penalized linear models generalized comparably, and none of the small-sample strategies or ensembling improved discrimination. Bootstrap correction reduced the apparent AUC from 0.965 to a corrected 0.724. Homocysteine ranked first in SHAP importance and was among ten independent factors in multivariable logistic regression. Conclusion Routine perioperative variables support a screening-oriented, interpretable prediction of AKI at the end of cardiac surgery, with modest discrimination. The lack of model superiority argues for parsimony, and homocysteine merits prospective study; external validation is required before clinical use.
Language: English
Subfield: Nephrology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7233920571
FWCI:
Cites: 32
Cited by:
Related to: 10
Parts: 1